{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T04:50:01Z","timestamp":1761540601148},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2005,2,3]],"date-time":"2005-02-03T00:00:00Z","timestamp":1107388800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2005,3]]},"DOI":"10.1007\/s00467-004-1788-2","type":"journal-article","created":{"date-parts":[[2005,2,2]],"date-time":"2005-02-02T13:06:13Z","timestamp":1107349573000},"page":"393-398","source":"Crossref","is-referenced-by-count":24,"title":["Are new vitamin D analogues in renal bone disease superior to calcitriol?"],"prefix":"10.1007","volume":"20","author":[{"given":"Isidro B.","family":"Salusky","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2005,2,3]]},"reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/S0272-6386(97)90330-9","volume":"29","author":"Martinez","year":"1997","unstructured":"Martinez I, Saracho R, Montenegro J, Llach F (1997) The importance of dietary calcium and phosphorus in the secondary hyperparathyroidism of patients with early renal failure. Am J Kidney Dis 29:496?502","journal-title":"Am J Kidney Dis"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1172\/JCI114840","volume":"86","author":"Naveh-Many","year":"1990","unstructured":"Naveh-Many T, Silver J (1990) Regulation of parathyroid hormone gene expression by hypocalcemia, hypercalcemia and vitamin D in the rat. J Clin Invest 86:1313?1319","journal-title":"J Clin Invest"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1046\/j.1523-1755.63.s85.12.x","volume":"63","author":"Coburn","year":"2003","unstructured":"Coburn JW, Maung HM (2003) Use of active vitamin D sterols in patients with chronic kidney disease, stages 3 and 4. Kidney Int 63:S49?S53","journal-title":"Kidney Int"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1056\/NEJM197802022980503","volume":"298","author":"Chesney","year":"1978","unstructured":"Chesney RW, Moorthy AV, Eisman JA, Tax DK, Mazess RB, DeLuca HF (1978) Increased growth after long-term oral 1,25-vitamin D3 in childhood renal osteodystrophy. N Engl J Med 298:238?242","journal-title":"N Engl J Med"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/S0022-3476(05)83128-2","volume":"124","author":"Chan","year":"1994","unstructured":"Chan JCM, McEnery PT, Chinchilli VM, Abitbol CL, Boineau FG, Friedman AL, Lum GM, Roy S III, Ruley EJ, Strife CF (1994) A prospective, double-blind study of growth failure in children with chronic renal insufficiency and the effectiveness of treatment with calcitriol versus dihydrotachysterol. J Pediatr 124:520?528","journal-title":"J Pediatr"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1007\/s00467-003-1091-7","volume":"18","author":"Schmitt","year":"2003","unstructured":"Schmitt CP, Ardissino G, Testa S, Appiani AC, Mehls O (2003) Growth in children with chronic renal failure on intermittent versus daily calcitriol. Pediatr Nephrol 18:440?444","journal-title":"Pediatr Nephrol"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1046\/j.1523-1755.1998.00724.x","volume":"53","author":"Kuizon","year":"1998","unstructured":"Kuizon BD, Goodman WG, J\u00fcppner H, Boechat I, Nelson P, Gales B, Salusky IB (1998) Diminished linear growth during treatment with intermittent calcitriol and dialysis in children with chronic renal failure. Kidney Int 53:205?211","journal-title":"Kidney Int"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1007\/s00467-003-1284-0","volume":"18","author":"Waller","year":"2003","unstructured":"Waller S, Ledermann S, Trompeter R, van?t Hoff W, Ridout D, Rees L (2003) Catch-up growth with normal parathyroid hormone levels in chronic renal failure. Pediatr Nephrol 18:1236?1241","journal-title":"Pediatr Nephrol"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0272-6386(86)80068-3","volume":"7","author":"Chesney","year":"1986","unstructured":"Chesney RW, Mehls O, Anast CS, Brown E, Hammerman MR, Portale A, Fallon MD, Mahan J Jr, Alfrey AC (1986) Renal osteodystrophy in children: the role of vitamin D, phosphorus, and parathyroid hormone. Am J Kidney Dis 7:275?284","journal-title":"Am J Kidney Dis"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1093\/clinchem\/33.8.1364","volume":"33","author":"Nussbaum","year":"1987","unstructured":"Nussbaum SR, Zahradnik RJ, Lavigne JR, Brennan GL, Nozawa-Ung C, Kim LY, Keutmann T, Wang CA, Potts JT Jr, Segre GV (1987) Highly sensitive two-site immunoradiometric assay of parathyrin, and its clinical utility in evaluating patients with hypercalcemia. Clin Chem 33:1364?1367","journal-title":"Clin Chem"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/ki.1993.64","volume":"43","author":"Sherrard","year":"1993","unstructured":"Sherrard DJ, Hercz G, Pei Y, Maloney N, Greenwood C, Manuel A, Saiphoo C, Fenton SS, Segre GV (1993) The spectrum of bone disease in end-stage renal failure?an evolving disorder. Kidney Int 43:436?442","journal-title":"Kidney Int"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1210\/jcem-73-3-516","volume":"73","author":"Cohen-Solal","year":"1991","unstructured":"Cohen-Solal ME, Sebert JL, Boudailliez B, Marie A, Moriniere Ph, Gueris J, Bouillon R, Fournier A (1991) Comparison of intact, midregion, and carboxy-terminal assays of parathyroid hormone for the diagnosis of bone disease in hemodialyzed patients. J Clin Endocrinol Metab 73:516?524","journal-title":"J Clin Endocrinol Metab"},{"key":"CR13","first-page":"145","volume":"75","author":"Quarles","year":"1992","unstructured":"Quarles LD, Lobaugh B, Murphy G (1992) Intact parathyroid hormone overestimates the presence and severity of parathyroid-mediated osseous abnormalities in uremia. J Clin Endocrinol Metab 75:145?150","journal-title":"J Clin Endocrinol Metab"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1681\/ASN.V3121938","volume":"12","author":"Mathias","year":"1993","unstructured":"Mathias RS, Salusky IB, Harmon WH, Paredes A, Emans J, Segre GV, Goodman WG (1993) Renal bone disease in pediatric patients and young adults treated by hemodialysis in a children?s hospital. J Am Soc Nephrol 12:1938?1946","journal-title":"J Am Soc Nephrol"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/ki.1994.31","volume":"45","author":"Salusky","year":"1994","unstructured":"Salusky IB, Ramirez JA, Oppenheim WL, Gales B, Segre GV, Goodman WG (1994) Biochemical markers of renal osteodystrophy in pediatric patients undergoing CAPD\/CCPD. Kidney Int 45:253?258","journal-title":"Kidney Int"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0085-2538(15)47156-X","volume":"58","author":"Slatopolsky","year":"2000","unstructured":"Slatopolsky E, Finch J, Clay P, Martin D, Sicard G, Singer G, Gao P, Cantor TL, Dusso A (2000) A novel mechanism for skeletal resistance in uremia. Kidney Int 58:753?761","journal-title":"Kidney Int"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1046\/j.1523-1755.2001.00949.x","volume":"60","author":"Monier-Faugere","year":"2001","unstructured":"Monier-Faugere MC, Geng Z, Mawad H, Friedler RM, Gao P, Cantor TL, Malluche HH (2001) Improved assessment of bone turnover by the PTH-(1?84)\/large C-PTH fragments ratio in ESRD patients. Kidney Int 60:1460?1468","journal-title":"Kidney Int"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1053\/ajkd.2002.34519","volume":"40","author":"Coen","year":"2002","unstructured":"Coen G, Bonucci E, Ballanti P, Balducci A, Calabria S, Nicolai GA, Fischer MS, Lifrieri F, Manni M, Morosetti M, Moscaritolo E, Sardella D (2002) PTH 1?84 and PTH ?7?84? in the noninvasive diagnosis of renal bone disease. Am J Kidney Dis 40:348?354","journal-title":"Am J Kidney Dis"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1046\/j.1523-1755.2003.00915.x","volume":"63","author":"Salusky","year":"2003","unstructured":"Salusky IB, Goodman WG, Kuizon BD, Lavigne JR, Zahranik RJ, Gales B, Wang HJ, Elashoff RM, Juppner H (2003) Similar predictive value of bone turnover using first- and second-generation immunometric PTH assays in pediatric patients treated with peritoneal dialysis. Kidney Int 63:1801?1808","journal-title":"Kidney Int"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S0022-3476(80)80479-3","volume":"97","author":"Norman","year":"1980","unstructured":"Norman ME, Mazur AT, Borden S, Gruskin A, Anast C, Baron R, Rasmussen H (1980) Early diagnosis of juvenile renal osteodystrophy. J Pediatr 97:226?232","journal-title":"J Pediatr"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/ki.1982.107","volume":"21","author":"Hodson","year":"1982","unstructured":"Hodson EM, Evans RA, Dunstan CR, Hills EE, Shaw PF (1982) Quantitative bone histology in children with chronic renal failure. Kidney Int 21:833?839","journal-title":"Kidney Int"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1542\/peds.70.5.742","volume":"70","author":"Hsu","year":"1982","unstructured":"Hsu AC, Kooh SW, Fraser D, Cumming WA, Fornasier VL (1982) Renal osteodystrophy in children with chronic renal failure: an unexpectedly common and incapacitating complication. Pediatrics 70:742?750","journal-title":"Pediatrics"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1136\/jcp.35.11.1283","volume":"35","author":"Smith","year":"1982","unstructured":"Smith PS, McClure J (1982) Localisation of aluminium by histochemical and electron probe x-ray microanalytical techniques in bone tissue of cases of renal osteodystrophy. J Clin Pathol 35:1283?1293","journal-title":"J Clin Pathol"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1651-2227.1994.tb17741.x","volume":"73","author":"Robitaille","year":"1984","unstructured":"Robitaille P, Marie PJ, Delvin EE, Lortie L, Glorieux FH (1984) Renal osteodystrophy in children treated with 1,25-dihydroxycholecalciferol [1,25-(OH)2 D3]. Histologic bone studies. Acta Pediatr Scand 73:315?324","journal-title":"Acta Pediatr Scand"},{"key":"CR25","first-page":"197","volume":"10","author":"Mehls","year":"1973","unstructured":"Mehls O, Krempien B, Ritz E, Scharer K, Schuler HW (1973) Renal osteodystrophy in children on maintenance hemodialysis. Proc EDTA 10:197?201","journal-title":"Proc EDTA"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/ki.1976.125","volume":"10","author":"Witmer","year":"1976","unstructured":"Witmer G, Margolis A, Fontaine O, Fritsch J, Lenoir G, Broyer M, Balsan S (1976) Effects of 25-hydroxycholecalciferol on bone lesions of children with terminal renal failure. Kidney Int 10:395?408","journal-title":"Kidney Int"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/ki.1988.96","volume":"33","author":"Salusky","year":"1988","unstructured":"Salusky IB, Coburn JW, Brill J, Foley J, Slatopolsky E, Fine RN, Goodman WG (1988) Bone disease in pediatric patients undergoing dialysis with CAPD or CCPD. Kidney Int 33:975?982","journal-title":"Kidney Int"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1136\/bmj.310.6976.358","volume":"310","author":"Hamdy","year":"1995","unstructured":"Hamdy NA, Kanis JA, Beneton MNC, Brown CB, Juttmann JR, Jordans JGM, Josse S, Meyrier A, Lins RL, Fairey IT (1995) Effect of alfacalcidol on natural course of renal bone disease in mild to moderate renal failure. Br Med J 310:358?363","journal-title":"Br Med J"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1210\/jcem-67-5-929","volume":"67","author":"Nordal","year":"1988","unstructured":"Nordal KP, Dahl E (1988) Low dose calcitriol versus placebo in patients with predialysis chronic renal failure. J Clin Endocrinol Metab 67:929?936","journal-title":"J Clin Endocrinol Metab"},{"key":"CR30","first-page":"375","volume":"12","author":"Coen","year":"1986","unstructured":"Coen G, Mazzaferro S, Bonucci E, Ballanti P, Massimetti C, Donato G, Landi A, Smacchi A, Della Rocca C, Cinotti GA (1986) Treatment of secondary hyperparathyroidism of predialysis chronic renal failure with low doses of 1,25(OH)2 D3: humoral and histomorphometric results. Miner Electrolyte Metab 12:375?382","journal-title":"Miner Electrolyte Metab"},{"key":"CR31","first-page":"1595","volume":"9","author":"Bianchi","year":"1994","unstructured":"Bianchi ML, Colantonio G, Campanini F, Rossi R, Valenti G, Ortolani S, Buccianti G (1994) Calcitriol and calcium carbonate therapy in early chronic renal failure. Nephrol Dial Transplant 9:1595?1599","journal-title":"Nephrol Dial Transplant"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1159\/000420142","volume":"90","author":"Goodman","year":"1991","unstructured":"Goodman WG, Salusky IB (1991) Evolution of secondary hyperparathyroidism during daily oral calcitriol therapy in pediatric renal osteodystrophy. Contrib Nephrol 90:189?195","journal-title":"Contrib Nephrol"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1056\/NEJM199102213240804","volume":"324","author":"Salusky","year":"1991","unstructured":"Salusky IB, Foley J, Nelson P, Goodman WG (1991) Aluminum accumulation during treatment with aluminum hydroxide and dialysis in children and young adults with chronic renal disease. N Engl J Med 324:527?531","journal-title":"N Engl J Med"},{"key":"CR34","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1172\/JCI111639","volume":"74","author":"Slatopolsky","year":"1984","unstructured":"Slatopolsky E, Weerts C, Thielan J, Horst RL, Harter H, Martin KJ (1984) Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxycholecalciferol in uremic patients. J Clin Invest 74:2136?2143","journal-title":"J Clin Invest"},{"key":"CR35","first-page":"421","volume":"315","author":"Fukagawa","year":"1990","unstructured":"Fukagawa M, Kitaoka M, Kaname S, Okazaki R, Matsumoto T, Ogata E, Hoshino M, Inada T, Sekine T, Kurokawa K (1990) Suppression of parathyroid gland hyperplasia by 1,25(OH)2 D3 pulse therapy. N Engl J Med 315:421?422","journal-title":"N Engl J Med"},{"key":"CR36","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1038\/ki.1994.223","volume":"45","author":"Quarles","year":"1994","unstructured":"Quarles LD, Yohay DA, Carroll BA, Spritzer CE, Minda SA, Bartholomay D, Lobaugh BA (1994) Prospective trial of pulse oral versus intravenous calcitriol treatment of hyperparathyroidism in ESRD. Kidney Int 45:1710?1721","journal-title":"Kidney Int"},{"key":"CR37","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1681\/ASN.V73488","volume":"7","author":"Levine","year":"1996","unstructured":"Levine BS, Song M (1996) Pharmacokinetics and efficacy of pulse oral versus intravenous calcitriol in hemodialysis patients. J Am Soc Nephrol 7:488?496","journal-title":"J Am Soc Nephrol"},{"key":"CR38","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1046\/j.1523-1755.1998.00045.x","volume":"54","author":"Salusky","year":"1998","unstructured":"Salusky IB, Kuizon BD, Belin T, Ramirez JA, Gales B, Segre GV, Goodman WG (1998) Intermittent calcitriol therapy in secondary hyperparathyroidism: a comparison between oral and intraperitoneal administration. Kidney Int 54:907?914","journal-title":"Kidney Int"},{"key":"CR39","doi-asserted-by":"crossref","unstructured":"Greenbaum LA, Genda R, Qiu P, Restaino I, Wojtak A, Paredes A, Benador N, Melnick JZ, Williams LA, Salusky IB (2004) Intravenous calcitriol for treatment of hyperparathyroidism in children on hemodialysis. Pediatr Nephrol (in press)","DOI":"10.1007\/s00467-004-1792-6"},{"key":"CR40","unstructured":"Salusky IB, Goodman WG, Norris KC, Horst R, Fine RN, Coburn JW (1988) Bioavailability of calcitriol after oral, intravenous and intraperitoneal doses in dialysis patients. In: Norman AW, Shaefer K, v. Herrath D, Grigoleit H-G (eds) Vitamin D: chemical, biochemical and clinical endocrinology of calcium metabolism. Walter de Gruyter, Berlin, pp 83?84"},{"key":"CR41","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1056\/NEJM198908033210502","volume":"321","author":"Andress","year":"1989","unstructured":"Andress DL, Norris KC, Coburn JW, Slatopolsky EA, Sherrard DJ (1989) Intravenous calcitriol in the treatment of refractory osteitis fibrosa of chronic renal failure. N Engl J Med 321:274?279","journal-title":"N Engl J Med"},{"key":"CR42","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/ki.1994.380","volume":"46","author":"Goodman","year":"1994","unstructured":"Goodman WG, Ramirez JA, Belin TR, Chon Y, Gales B, Segre GV, Salusky IB (1994) Development of adynamic bone in patients with secondary hyperparathyroidism after intermittent calcitriol therapy. Kidney Int 46:1160?1166","journal-title":"Kidney Int"},{"key":"CR43","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1681\/ASN.V1291978","volume":"12","author":"Salusky","year":"2001","unstructured":"Salusky IB, Goodman WG (2001) Adynamic renal osteodystrophy: Is there a problem? J Am Soc Nephrol 12:1978?1985","journal-title":"J Am Soc Nephrol"},{"key":"CR44","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1097\/00005792-197311000-00005","volume":"52","author":"Kopple","year":"1973","unstructured":"Kopple JD, Coburn JW (1973) Metabolic studies of low protein diets in uremia: II. Calcium, phosphorus and magnesium. Medicine 52:597?607","journal-title":"Medicine"},{"key":"CR45","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/ki.1990.293","volume":"38","author":"Milliner","year":"1990","unstructured":"Milliner DS, Zinsmeister AR, Lieberman E, Landing B (1990) Soft tissue calcification in pediatric patients with end-stage renal disease. Kidney Int 38:931?936","journal-title":"Kidney Int"},{"key":"CR46","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1053\/ajkd.1998.v32.pm9820470","volume":"32","author":"Foley","year":"1998","unstructured":"Foley RN, Parfrey PS, Sarnak MJ (1998) Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 32:S112?S119","journal-title":"Am J Kidney Dis"},{"key":"CR47","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1161\/01.CIR.0000020222.63035.C0","volume":"106","author":"Oh","year":"2002","unstructured":"Oh J, Wunsch R, Turzer M, Bahner M, Raggi P, Querfeld U, Mehls O, Schaefer F (2002) Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure. Circulation 106:100?105","journal-title":"Circulation"},{"key":"CR48","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1172\/JCI114229","volume":"84","author":"Brown","year":"1989","unstructured":"Brown AJ, Ritter CR, Finch JL, Morrissey J, Martin KJ, Murayama E, Nishii Y, Slatopolsky E (1989) The noncalcemic analogue of vitamin D, 22-oxacalcitriol, suppresses parathyroid hormone synthesis and secretion. J Clin Invest 84:728?732","journal-title":"J Clin Invest"},{"key":"CR49","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1210\/endo.133.3.8396012","volume":"133","author":"Brown","year":"1993","unstructured":"Brown AJ, Finch J, Grieff M, Ritter C, Kubodera N, Nishii Y, Slatopolsky E (1993) The mechanism for the disparate actions of calcitriol and 22-oxacalcitriol in the intestine. Endocrinology 133:1158?1164","journal-title":"Endocrinology"},{"key":"CR50","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0272-6386(97)90571-0","volume":"30","author":"Takahashi","year":"1997","unstructured":"Takahashi F, Finch JL, Denda M, Dusso AS, Brown AJ, Slatopolsky E (1997) A new analog of 1,25-(OH)2 D3, 19-nor-1,25-(OH)2 D2, suppresses serum PTH and parathyroid gland growth in uremic rats without elevation of intestinal vitamin D receptor content. Am J Kidney Dis 30:105?112","journal-title":"Am J Kidney Dis"},{"key":"CR51","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/ki.1996.283","volume":"50","author":"Denda","year":"1996","unstructured":"Denda M, Finch J, Brown AJ, Nishii Y, Kubodera N, Slatopolsky E (1996) 1,25-Dihydroxyvitamin D3 and 22-oxacalcitriol prevent the decrease in vitamin D receptor content in the parathyroid glands of uremic rats. Kidney Int 50:34?39","journal-title":"Kidney Int"},{"key":"CR52","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1046\/j.1523-1755.1999.00772.x","volume":"56","author":"Hirata","year":"1999","unstructured":"Hirata M, Katsumata K, Masaki T, Koike N, Endo K, Tsunemi K, Ohkawa H, Kurokawa K, Fukagawa M (1999) 22-Oxacalcitriol ameliorates high-turnover bone and marked osteitis fibrosa in rats with slowly progressive nephritis. Kidney Int 56:2040?2047","journal-title":"Kidney Int"},{"key":"CR53","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1046\/j.1523-1755.1999.055003821.x","volume":"55","author":"Monier-Faugere","year":"1999","unstructured":"Monier-Faugere MC, Geng Z, Friedler RM, Qi Q, Kubodera N, Slatopolsky E, Malluche HH (1999) 22-Oxacalcitriol suppresses secondary hyperparathyroidism without inducing low bone turnover in dogs with renal failure. Kidney Int 55:821?832","journal-title":"Kidney Int"},{"key":"CR54","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/ndt\/11.supp3.121","volume":"11","author":"Kurokawa","year":"1996","unstructured":"Kurokawa K, Akizawa T, Suzuki M, Akiba T, Ogata E, Slatopolsky E (1996) Effect of 22-oxacalcitriol on hyperparathyroidism of dialysis patients: results of preliminary study. Nephrol Dial Transplant 11:121?124","journal-title":"Nephrol Dial Transplant"},{"key":"CR55","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/S0272-6386(00)70198-3","volume":"35","author":"Tsukamoto","year":"2000","unstructured":"Tsukamoto Y, Hanaoka M, Matsuo T, Saruta T, Nomura M, Takahashi Y (2000) Effect of 22-oxacalcitriol on bone histology of hemodialyzed patients with severe secondary hyperparathyroidism. Am J Kidney Dis 35:458?464","journal-title":"Am J Kidney Dis"},{"key":"CR56","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/0272-6386(95)90455-7","volume":"26","author":"Slatopolsky","year":"1995","unstructured":"Slatopolsky E, Finch J, Ritter C, Denda M, Morrissey J, Brown A, DeLuca H (1995) A new analog of calcitriol, 19-nor-1,25-(OH)2 D2, suppresses parathyroid hormone secretion in uremic rats in the absence of hypercalcemia. Am J Kidney Dis 26:852?860","journal-title":"Am J Kidney Dis"},{"key":"CR57","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1053\/ajkd.2001.28110","volume":"38","author":"Sprague","year":"2001","unstructured":"Sprague SM, Lerma E, McCormmick D, Abraham M, Batlle D (2001) Suppression of parathyroid hormone secretion in hemodialysis patients: comparison of paricalcitol with calcitriol. Am J Kidney Dis 38:S51?S56","journal-title":"Am J Kidney Dis"},{"key":"CR58","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1056\/NEJMoa022536","volume":"349","author":"Teng","year":"2003","unstructured":"Teng M, Wolf M, Lowrie EG, Ofsthun N, Lazarus JM, Thadhani RI (2003) Survival of patients undergoing hemodialysis with paracalcitol or calcitriol therapy. N Engl J Med 349:446?456","journal-title":"N Engl J Med"},{"key":"CR59","doi-asserted-by":"crossref","first-page":"432","DOI":"10.3181\/00379727-178-42028","volume":"178","author":"Sj","year":"1985","unstructured":"Sj\u00f6den G, Smith C, Lindgren JU, DeLuca HF (1985) 1?-Hydroxyvitamin D2 is less toxic than 1?-hydroxyvitamin D3 in the rat. Proc Soc Exp Biol Med 178:432?436","journal-title":"Proc Soc Exp Biol Med"},{"key":"CR60","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/ki.1997.39","volume":"51","author":"Tan","year":"1997","unstructured":"Tan AU Jr, Levine BS, Mazess RB, Kyllo DM, Bishop CW, Knutson JC, Kleinman KS, Coburn JW (1997) Effective suppression of parathyroid hormone by 1 alpha-hydroxy-vitamin D2 in hemodialysis patients with moderate to severe secondary hyperparathyroidism. Kidney Int 51:317?323","journal-title":"Kidney Int"},{"key":"CR61","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1093\/ndt\/13.suppl_3.68","volume":"3","author":"Frazao","year":"1998","unstructured":"Frazao J, Chesney RW, Coburn JW (1998) Intermittent oral 1alpha-hydroxyvitamin D2 is effective and safe for the suppression of secondary hyperparathyroidism in haemodialysis patients. 1alphaD2 Study Group. Nephrol Dial Transplant 13 Suppl 3:68?72","journal-title":"Nephrol Dial Transplant 13 Suppl"},{"key":"CR62","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1053\/j.ajkd.2004.01.012","volume":"43","author":"Coburn","year":"2004","unstructured":"Coburn JW, Maung HM, Elangovan L, Germain MJ, Lindberg JS, Sprague SM, Williams ME, Bishop CW (2004) Doxercalciferol safely suppresses PTH levels in patients with secondary hyperparathyroidism associated with chronic kidney disease stages 3 and 4. Am J Kidney Dis 43:877?890","journal-title":"Am J Kidney Dis"},{"key":"CR63","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1046\/j.1523-1755.2002.00434.x","volume":"62","author":"Chertow","year":"2002","unstructured":"Chertow GM, Burke SK, Raggi P (2002) Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int 62:245?252","journal-title":"Kidney Int"},{"key":"CR64","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0272-6386(03)00554-7","volume":"42","author":"Joy","year":"2003","unstructured":"Joy MS, Finn WF, LAM-302 Study Group (2003) Randomized, double-blind, placebo-controlled, dose-titration, phase III study assessing the efficacy and tolerability of lanthanum carbonate: a new phosphate binder for the treatment of hyperphosphatemia. Am J Kidney Dis 42:96?107","journal-title":"Am J Kidney Dis"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-004-1788-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-004-1788-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-004-1788-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T23:24:44Z","timestamp":1682983484000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-004-1788-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2,3]]},"references-count":64,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,3]]}},"alternative-id":["1788"],"URL":"https:\/\/doi.org\/10.1007\/s00467-004-1788-2","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,2,3]]}}}